MIST•benzinga•
Milestone Pharmaceuticals FY 2024 GAAP EPS $(0.67) Misses $(0.62) Estimate, Cash Balance Of $69.7M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 13, 2025 by benzinga